BioCentury | Aug 18, 2020
Product Development

Unity outlines path forward for anti-aging programs after Phase II osteoarthritis failure

...will provide runway into 2022. The company entered into an $80 million debt facility with Hercules Capital...
BioCentury | Jul 19, 2019
Company News

Management tracks: Iovance, ViiV, Hercules, Pappas and more

...that includes GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), Pfizer Inc. (NYSE:PFE) and Shionogi & Co. Ltd. (Tokyo:4507). Hercules Capital...
...head of clinical development at Zafgen Inc. (NASDAQ:ZFGN). BioCentury Staff Acacia Pharma Group plc Aurinia Pharmaceuticals Inc. Escient Pharmaceuticals Inc. Hercules Capital Immunic...
BioCentury | May 21, 2019
Finance

Debt and equity investor K2HV seeks ‘profit and purpose’ in $400M launch

...will be a permanent capital base. The firm, whose founding managing director and CEO is Hercules Capital...
...declined to say from whom; its capital pool would also grow via returns. Paul Bonanos, Assistant Editor Hercules Capital K2...
BioCentury | Mar 28, 2019
Clinical News

Tricida gains on long-term Phase III data for metabolic acidosis therapy

...Metabolic Acidosis" ). The company also announced Thursday it amended its existing debt facility with Hercules Capital...
BioCentury | Mar 26, 2019
Clinical News

Aldeyra's allergic conjunctivitis therapy clears Phase III hurdle

...discuss a potential NDA submission. Also on Tuesday, Aldeyra said it entered an agreement with Hercules Capital...
BioCentury | Mar 13, 2019
Company News

Management tracks: Hercules CEO steps down amid college admissions scandal

Hercules Capital said Manuel Henriquez stepped down as chairman and CEO. Henriquez and his wife were charged Tuesday as part of a wide-ranging college admissions cheating scheme. The firm's board elected Robert Badavas, lead independent...
BioCentury | Mar 8, 2019
Financial News

TG raises $55.2M in debt and equity financings

...NASDAQ:TGTX) also said it drew down $30 million of a $60 million loan facility with Hercules Capital. Shannon...
BioCentury | Mar 8, 2019
Financial News

Urovant draws down $15M in loan facility

...Urology-focused biotech Urovant drew down $15 million under a newly announced loan facility with Hercules Capital. Urovant...
BioCentury | Feb 28, 2019
Clinical News

TG aims for accelerated approval of lymphoma candidate

...said it closed a $30 million tranche of a $60 million debt financing agreement with Hercules Capital...
BioCentury | Jan 25, 2019
Financial News

BridgeBio raises $299M to advance rare disease portfolio

...co-led the new financing. Fellow existing investors Perceptive Advisors, AIG, Aisling Capital, Cormorant Capital and Hercules Capital...
Items per page:
1 - 10 of 17
BioCentury | Aug 18, 2020
Product Development

Unity outlines path forward for anti-aging programs after Phase II osteoarthritis failure

...will provide runway into 2022. The company entered into an $80 million debt facility with Hercules Capital...
BioCentury | Jul 19, 2019
Company News

Management tracks: Iovance, ViiV, Hercules, Pappas and more

...that includes GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), Pfizer Inc. (NYSE:PFE) and Shionogi & Co. Ltd. (Tokyo:4507). Hercules Capital...
...head of clinical development at Zafgen Inc. (NASDAQ:ZFGN). BioCentury Staff Acacia Pharma Group plc Aurinia Pharmaceuticals Inc. Escient Pharmaceuticals Inc. Hercules Capital Immunic...
BioCentury | May 21, 2019
Finance

Debt and equity investor K2HV seeks ‘profit and purpose’ in $400M launch

...will be a permanent capital base. The firm, whose founding managing director and CEO is Hercules Capital...
...declined to say from whom; its capital pool would also grow via returns. Paul Bonanos, Assistant Editor Hercules Capital K2...
BioCentury | Mar 28, 2019
Clinical News

Tricida gains on long-term Phase III data for metabolic acidosis therapy

...Metabolic Acidosis" ). The company also announced Thursday it amended its existing debt facility with Hercules Capital...
BioCentury | Mar 26, 2019
Clinical News

Aldeyra's allergic conjunctivitis therapy clears Phase III hurdle

...discuss a potential NDA submission. Also on Tuesday, Aldeyra said it entered an agreement with Hercules Capital...
BioCentury | Mar 13, 2019
Company News

Management tracks: Hercules CEO steps down amid college admissions scandal

Hercules Capital said Manuel Henriquez stepped down as chairman and CEO. Henriquez and his wife were charged Tuesday as part of a wide-ranging college admissions cheating scheme. The firm's board elected Robert Badavas, lead independent...
BioCentury | Mar 8, 2019
Financial News

TG raises $55.2M in debt and equity financings

...NASDAQ:TGTX) also said it drew down $30 million of a $60 million loan facility with Hercules Capital. Shannon...
BioCentury | Mar 8, 2019
Financial News

Urovant draws down $15M in loan facility

...Urology-focused biotech Urovant drew down $15 million under a newly announced loan facility with Hercules Capital. Urovant...
BioCentury | Feb 28, 2019
Clinical News

TG aims for accelerated approval of lymphoma candidate

...said it closed a $30 million tranche of a $60 million debt financing agreement with Hercules Capital...
BioCentury | Jan 25, 2019
Financial News

BridgeBio raises $299M to advance rare disease portfolio

...co-led the new financing. Fellow existing investors Perceptive Advisors, AIG, Aisling Capital, Cormorant Capital and Hercules Capital...
Items per page:
1 - 10 of 17